Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-7723
Full metadata record
DC FieldValueLanguage
dc.contributor.authorStaubach, Petra-
dc.contributor.authorMann, Caroline-
dc.contributor.authorPeveling- Oberhag, Adriane-
dc.contributor.authorLang, Berenice M.-
dc.contributor.authorAugustin, Matthias-
dc.contributor.authorHagenström, Kristina-
dc.contributor.authorGarbe, Claudia-
dc.contributor.authorPetersen, Jana-
dc.date.accessioned2022-09-12T10:13:45Z-
dc.date.available2022-09-12T10:13:45Z-
dc.date.issued2021-
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/7738-
dc.description.abstractBackground To date, robust epidemiological metrics as well as data on comorbidity in pediatric urticaria are lacking. They form the basis for the design of efficient healthcare. Methods Retrospective study to analyze epidemiological data in pediatric urticaria. The analysis is based on routine data of a health insurance company operating throughout Germany (DAK-Gesundheit). Insured people under 18 years of age who received at least one confirmed outpatient or inpatient urticaria diagnosis according to the ICD-10 classification in the years 2010 to 2015 were included in the analysis and compared to children without a corresponding diagnosis. Results Of 2.3 million insured individuals, 313,581 (13.5 %) were under 18 years of age (153,214 female). Urticaria was diagnosed in 1.7 % of the 313,581 patients. The prevalence of urticaria decreased with age from 3.0 % in the 0–3-year age group to 1.0 % in the 14–18-year age group. Boys and girls were almost equally affected in all age groups. Atopic diseases as comorbidity occurred more frequently in children with urticaria than in the control group (16.0 % vs. 8.0 %). Autoimmune diseases, mental health problems, and obesity also occurred more frequently in children with urticaria than in the control group. Conclusions The increased prevalence of specific comorbidities in children with urticaria suggests an increased need for screening. Multimodal treatment strategies need to be developed and interdisciplinary collaboration promoted.en_GB
dc.language.isoengde
dc.rightsCC BY-NC*
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/*
dc.subject.ddc610 Medizinde_DE
dc.subject.ddc610 Medical sciencesen_GB
dc.titleEpidemiology of urticaria in German childrenen_GB
dc.typeZeitschriftenaufsatzde
dc.identifier.doihttp://doi.org/10.25358/openscience-7723-
jgu.type.dinitypearticleen_GB
jgu.type.versionPublished versionde
jgu.type.resourceTextde
jgu.organisation.departmentFB 04 Medizinde
jgu.organisation.number2700-
jgu.organisation.nameJohannes Gutenberg-Universität Mainz-
jgu.rights.accessrightsopenAccess-
jgu.journal.titleJournal der Deutschen Dermatologischen Gesellschaftde
jgu.journal.volume19de
jgu.journal.issue7de
jgu.pages.start1013de
jgu.pages.end1019de
jgu.publisher.year2021-
jgu.publisher.nameWiley-Blackwellde
jgu.publisher.placeBerlinde
jgu.publisher.issn1610-0387de
jgu.organisation.placeMainz-
jgu.subject.ddccode610de
jgu.publisher.doi10.1111/ddg.14485de
jgu.organisation.rorhttps://ror.org/023b0x485-
Appears in collections:JGU-Publikationen

Files in This Item:
  File Description SizeFormat
Thumbnail
epidemiology_of_urticaria_in_-20220912121433768.pdf147.35 kBAdobe PDFView/Open